应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TRDA Entrada Therapeutics, Inc.
交易中 07-11 13:40:10 EDT
6.58
-0.18
-2.66%
最高
6.82
最低
6.55
成交量
8.42万
今开
6.75
昨收
6.76
日振幅
4.00%
总市值
2.50亿
流通市值
1.40亿
总股本
3,795万
成交额
56.25万
换手率
0.39%
流通股本
2,135万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Entrada Therapeutics, Inc.盘中异动 早盘快速拉升5.86%
市场透视 · 05-09
Entrada Therapeutics, Inc.盘中异动 早盘快速拉升5.86%
Entrada Therapeutics, Inc.盘中异动 早盘股价大跌5.39%
市场透视 · 05-06
Entrada Therapeutics, Inc.盘中异动 早盘股价大跌5.39%
Entrada Therapeutics, Inc.盘中异动 快速拉升5.03%报8.35美元
市场透视 · 04-22
Entrada Therapeutics, Inc.盘中异动 快速拉升5.03%报8.35美元
Entrada Therapeutics 2024年第四季度GAAP每股收益$0.03超过预期$(0.67),销售额$37.40M超过预期$13.12M
财报速递 · 02-27
Entrada Therapeutics 2024年第四季度GAAP每股收益$0.03超过预期$(0.67),销售额$37.40M超过预期$13.12M
Entrada Therapeutics, Inc.盘中异动 早盘股价大涨5.23%报17.72美元
市场透视 · 2024-10-25
Entrada Therapeutics, Inc.盘中异动 早盘股价大涨5.23%报17.72美元
加载更多
公司概况
公司名称:
Entrada Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Entrada Therapeutics, Inc.于2016年9月22日根据特拉华州法律注册成立。该公司旨在通过将内体逃逸载体(EEV)疗法确立为一种新型药物来改变患者的生活,并致力于成为世界上最重要的细胞内疗法公司。该公司的EEV疗法旨在处理长期以来被认为无法接近和无法成药的细胞内靶标。通过其专有的、高度通用的模块化EEV平台,该公司正在构建强大的EEV治疗候选药物开发组合,旨在使治疗剂在各种器官和组织中有效细胞内递送,并提高治疗指数。该公司相信,早期项目的潜在成功可以转化为有效开发其他EEV治疗候选药物,并能够在罕见疾病、免疫学和肿瘤学方面建立投资组合。
发行价格:
--
{"stockData":{"symbol":"TRDA","market":"US","secType":"STK","nameCN":"Entrada Therapeutics, Inc.","latestPrice":6.58,"timestamp":1752255606888,"preClose":6.76,"halted":0,"volume":84217,"delay":0,"floatShares":21346400,"shares":37953417,"eps":0.606708,"marketStatus":"交易中","change":-0.18,"latestTime":"07-11 13:40:10 EDT","open":6.75,"high":6.8207,"low":6.5506,"amount":562453.172106,"amplitude":0.039956,"askPrice":6.59,"askSize":253,"bidPrice":6.57,"bidSize":230,"shortable":0,"etf":0,"ttmEps":0.606708,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752264000000},"marketStatusCode":2,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":6.76,"preHourTrading":{"tag":"盘前","latestPrice":6.78,"preClose":6.76,"latestTime":"09:29 EDT","volume":1327,"amount":9042.5502235,"timestamp":1752240569082},"postHourTrading":{"tag":"盘后","latestPrice":6.86,"preClose":6.76,"latestTime":"19:59 EDT","volume":612,"amount":4166.1677,"timestamp":1752191981660},"volumeRatio":0.95863,"impliedVol":1.0955,"impliedVolPercentile":0.544},"requestUrl":"/m/hq/s/TRDA","defaultTab":"news","newsList":[{"id":"2534761480","title":"Entrada Therapeutics, Inc.盘中异动 早盘快速拉升5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534761480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534761480?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:44","pubTimestamp":1746798264,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时44分,Entrada Therapeutics, Inc.股票出现异动,股价快速拉升5.86%。Entrada Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.39%。Entrada Therapeutics, Inc.公司简介:Entrada Therapeutics Inc临床阶段生物制药公司,旨在通过建立一类新的药物来改变患者的生活,这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214432a4784025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214432a4784025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRDA","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2533963479","title":"Entrada Therapeutics, Inc.盘中异动 早盘股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533963479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533963479?lang=zh_cn&edition=full","pubTime":"2025-05-06 21:40","pubTimestamp":1746538858,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日21时40分,Entrada Therapeutics, Inc.股票出现波动,股价大幅下跌5.39%。Entrada Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为2.78%。Entrada Therapeutics, Inc.公司简介:Entrada Therapeutics Inc临床阶段生物制药公司,旨在通过建立一类新的药物来改变患者的生活,这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506214058aa2c843f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506214058aa2c843f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","TRDA","LENZ"],"gpt_icon":0},{"id":"2529658464","title":"Entrada Therapeutics, Inc.盘中异动 快速拉升5.03%报8.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529658464","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529658464?lang=zh_cn&edition=full","pubTime":"2025-04-22 22:06","pubTimestamp":1745330769,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日22时06分,Entrada Therapeutics, Inc.股票出现波动,股价大幅上涨5.03%。Entrada Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.28%。Entrada Therapeutics, Inc.公司简介:Entrada Therapeutics Inc临床阶段生物制药公司,旨在通过建立一类新的药物来改变患者的生活,这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042222060994de3c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042222060994de3c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","TRDA","BK4139"],"gpt_icon":0},{"id":"1142220963","title":"Entrada Therapeutics 2024年第四季度GAAP每股收益$0.03超过预期$(0.67),销售额$37.40M超过预期$13.12M","url":"https://stock-news.laohu8.com/highlight/detail?id=1142220963","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142220963?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:12","pubTimestamp":1740658350,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics 公布季度每股收益为$0.03,超过分析师一致预期$,超出104.48%。公司季度销售额为$37.40百万,超过分析师一致预期的$13.12百万,超出185.04%。与去年同期$41.85百万的销售额相比,减少了10.63%。以上内容来自Benzinga Earnings专栏,原文如下:Entrada $Therapeutics$ reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $ by 104.48 percent. This is a 110.34 percent increase over losses of $ per share from the same period last year. The company reported quarterly sales of $37.40 million which beat the analyst consensus estimate of $13.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","LENZ"],"gpt_icon":0},{"id":"2478372279","title":"Entrada Therapeutics, Inc.盘中异动 早盘股价大涨5.23%报17.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478372279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478372279?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:07","pubTimestamp":1729868847,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时07分,Entrada Therapeutics, Inc.股票出现波动,股价大幅拉升5.23%。Entrada Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.85%。Entrada Therapeutics, Inc.公司简介:Entrada Therapeutics Inc临床阶段生物制药公司,旨在通过建立一类新的药物来改变患者的生活,这些药物涉及长期以来被认为难以接近的细胞内靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523072798e3e89c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523072798e3e89c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRDA","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.entradatx.com","stockEarnings":[{"period":"1week","weight":-0.065},{"period":"1month","weight":-0.1816},{"period":"3month","weight":-0.1443},{"period":"6month","weight":-0.5386},{"period":"1year","weight":-0.5705},{"period":"ytd","weight":-0.609}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Entrada Therapeutics, Inc.于2016年9月22日根据特拉华州法律注册成立。该公司旨在通过将内体逃逸载体(EEV)疗法确立为一种新型药物来改变患者的生活,并致力于成为世界上最重要的细胞内疗法公司。该公司的EEV疗法旨在处理长期以来被认为无法接近和无法成药的细胞内靶标。通过其专有的、高度通用的模块化EEV平台,该公司正在构建强大的EEV治疗候选药物开发组合,旨在使治疗剂在各种器官和组织中有效细胞内递送,并提高治疗指数。该公司相信,早期项目的潜在成功可以转化为有效开发其他EEV治疗候选药物,并能够在罕见疾病、免疫学和肿瘤学方面建立投资组合。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.177963},{"month":2,"riseRate":0.5,"avgChangeRate":-0.01461},{"month":3,"riseRate":0.5,"avgChangeRate":-0.065115},{"month":4,"riseRate":0.25,"avgChangeRate":-0.177334},{"month":5,"riseRate":0.5,"avgChangeRate":0.061748},{"month":6,"riseRate":0.5,"avgChangeRate":0.23206},{"month":7,"riseRate":1,"avgChangeRate":0.089984},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.030387},{"month":9,"riseRate":0.666667,"avgChangeRate":0.074673},{"month":10,"riseRate":1,"avgChangeRate":0.177316},{"month":11,"riseRate":0.5,"avgChangeRate":-0.032287},{"month":12,"riseRate":0.25,"avgChangeRate":-0.122311}],"exchange":"NASDAQ","name":"Entrada Therapeutics, Inc.","nameEN":"Entrada Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Entrada Therapeutics, Inc.(TRDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Entrada Therapeutics, Inc.(TRDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Entrada Therapeutics, Inc.,TRDA,Entrada Therapeutics, Inc.股票,Entrada Therapeutics, Inc.股票老虎,Entrada Therapeutics, Inc.股票老虎国际,Entrada Therapeutics, Inc.行情,Entrada Therapeutics, Inc.股票行情,Entrada Therapeutics, Inc.股价,Entrada Therapeutics, Inc.股市,Entrada Therapeutics, Inc.股票价格,Entrada Therapeutics, Inc.股票交易,Entrada Therapeutics, Inc.股票购买,Entrada Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Entrada Therapeutics, Inc.(TRDA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Entrada Therapeutics, Inc.(TRDA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}